Cargando…

Endothelial dysfunction in patients with non-alcoholic steatohepatitis

Detalles Bibliográficos
Autor principal:	Onal, Ibrahim Koral
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2014
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116770/ https://www.ncbi.nlm.nih.gov/pubmed/24397312 http://dx.doi.org/10.3109/03009734.2013.872736

Ejemplares similares

Determinants of endothelial dysfunction in patients with non-alcoholic steatohepatitis
por: Sarli, Bahadir, et al.
Publicado: (2014)

Burden of non-alcoholic steatohepatitis among children with type 2 diabetes mellitus
por: Parlett, Lauren, et al.
Publicado: (2021)

Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis
por: Arinc, Huseyin, et al.
Publicado: (2013)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

COGNITIVE DYSFUNCTION IN ALCOHOLICS
por: Andrade, Chitra A., et al.
Publicado: (1992)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

COVID-19 and Erectile Dysfunction: Endothelial Dysfunction and Beyond
por: Sansone, Andrea, et al.
Publicado: (2021)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients
por: Falcinelli, Emanuela, et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Biochemical Scoring System for diagnosing Nonalcoholic Steatohepatitis
por: Noor-E-Alam, Mohammad, et al.
Publicado: (2016)

Letter: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267–76)
por: Yu, Sung Hoon
Publicado: (2020)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver
por: Gupta, Tarana
Publicado: (2022)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Therapeutic approaches for non-alcoholic steatohepatitis
por: Van Gaal, Luc F., et al.
Publicado: (2021)

Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2020)

Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk
por: Al-hamoudi, Waleed, et al.
Publicado: (2020)

Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2022)

Placental extract ameliorates non-alcoholic steatohepatitis (NASH) by exerting protective effects on endothelial cells
por: Yamauchi, Akihiro, et al.
Publicado: (2017)

Expansion of macrophage and liver sinusoidal endothelial cell subpopulations during non-alcoholic steatohepatitis progression
por: Shen, Zhenyang, et al.
Publicado: (2023)

The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice
por: Bae, Cho-Rong, et al.
Publicado: (2020)

Tamoxifen and fulvestrant induced steatohepatitis with cirrhosis: A rare case report
por: Roy, Somnath, et al.
Publicado: (2019)

In response to the letter to the editor regarding “Comparison of the intubation success rate between the intubating catheter and videolaryngoscope in difficult airways: a prospective randomized trial”
por: Onal, Ozkan, et al.
Publicado: (2023)

Time course of endothelial dysfunction markers and mortality in COVID‐19 patients: A pilot study
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2021)

Polymorphisms and Haplotypes in Candidate Genes Related to Angiogenesis and Endothelial Dysfunction in Preeclampsia
por: Luizon, Marcelo Rizzatti, et al.
Publicado: (2012)

Endothelial dysfunction and COVID-19: What's the true impact on surrogate outcomes?
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
por: Brar, Gurmehr, et al.
Publicado: (2019)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
por: Vonghia, Luisa, et al.
Publicado: (2013)

Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical Management
por: Salomone, Federico, et al.
Publicado: (2015)

Conophylline inhibits non-alcoholic steatohepatitis in mice
por: Nakade, Yukiomi, et al.
Publicado: (2017)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
por: Zhu, Bo, et al.
Publicado: (2021)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Mechanisms of ductular reaction in non-alcoholic steatohepatitis
por: Chen, Yue, et al.
Publicado: (2022)

Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
por: Branković, Marija, et al.
Publicado: (2022)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
por: Adrian, Therese, et al.
Publicado: (2022)

Left ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis
por: Marella, Hemnishil K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cd65sc3dbegkhpsk47jghnv4qc